Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07102615 · ClinicalTrials.gov registry record · Phase 4
Intracervical Vasopressin
A Phase 4 study of Retained Products of Conception, sponsored by Prisma Health-Upstate.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07102615 is a Phase 4 study of Retained Products of Conception that is actively recruiting participants, run by Prisma Health-Upstate. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07102615, a Phase 4 study of Retained Products of Conception, is actively recruiting participants, sponsored by Prisma Health-Upstate.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized study looks at whether using a medicine injected into the cervix of the uterus (intracervical), called vasopressin, helps to achieve better removal of retained products of conception (RPOC). RPOC means that after a pregnancy has ended (through miscarriage, abortion, or delivery), some parts of the pregnancy tissue, usually from the placenta or fetus, have stayed in the uterus. A hysteroscopic removal of RPOC is one type of treatment. This is a surgical procedure where a doctor uses a small camera attached to a thin tube (called a hysteroscope) to look inside the uterus. The main goal of the study is : • To add to the existing research through this study to see if the injection of intracervical vasopressin leads to improved completion rates of hysteroscopic management of RPOC. Participants will: • would be randomized to receive either vasopressin intracervical injection or a placebo injection (non-active saline) during your procedure. Information from the procedure will be collected from the participant's medical record.
Conditions Studied
Interventions
- DRUG Intracervical injection of Vasopressin
- DRUG Intracervical Injection of saline
Study Locations (1)
South Carolina
- The OB/GYN Center - Greenville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-10-30 |
| Est. Completion | 2026-12-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07102615
The ClinicalTrials.gov registry entry for NCT07102615 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Prisma Health-Upstate, which has 67 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Retained Products of Conception appearing as the primary indexed condition, and to 2 interventions - of which Intracervical injection of Vasopressin is the first listed.
NCT07102615 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT07102615 about?
NCT07102615 is a clinical study titled "Intracervical Vasopressin". This randomized study looks at whether using a medicine injected into the cervix of the uterus (intracervical), called vasopressin, helps to achieve better removal of retained products of conception (RPOC). RPOC means that after a pregnancy has ended (through miscarriage, abortion, or delivery), som...
What is the current status of trial NCT07102615?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2025-10-30. Estimated completion is 2026-12-01.
What conditions does trial NCT07102615 study?
This clinical trial studies the following conditions: Retained Products of Conception.
What interventions are being tested in trial NCT07102615?
The interventions under investigation include: Intracervical injection of Vasopressin (DRUG), Intracervical Injection of saline (DRUG).
Who is sponsoring clinical trial NCT07102615?
This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07102615 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.